RegBase
日本語
Japanese original

塩野義製薬株式会社

塩野義製薬株式会社· Corporate Number: 9120001077430

塩野義製薬株式会社は、大阪府大阪市中央区道修町に本店を置く企業である。2022年11月に薬事法、薬機法、および医薬品医療機器等法に関する行政処分を受けている。

For developers: integration details

You do not need this for normal browsing. Use it when integrating this company record into an internal tool or AI workflow.

/api/v1/search?q=9120001077430&limit=5
Open API responseAPI docs

Public Record Summary

Actions in last 3 years
0records
Actions in last year
0records
Latest action
about 3 years ago

22 Nov 2022

Total penalties
-

Repeated actions: 5 actions are recorded for this company. Multiple actions under the same law may be relevant when reviewing repeat compliance issues.

Enforcement and administrative action history

医薬品医療機器等法緊急承認
Confirmed entity match

Emergency approval for a treatment drug related to the novel coronavirus infection.

22 Nov 2022Ministry of Health, Labour and Welfare
Open source archiveCheck original source
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices先駆け審査指定制度対象品目の募集
RepeatConfirmed entity match

The Ministry of Health, Labour and Welfare established the 'Designated Priority Review System' on April 1, 2015, to promote the development of innovative pharmaceuticals, medical devices, regenerative medicine products, etc., with the aim of early practical application in Japan.

5 Oct 2017Ministry of Health, Labour and Welfare
Open source archiveCheck original source
薬事法先駆け審査指定制度対象品目の募集
Confirmed entity match

S-033188 Influenza virus infection type A or B

5 Oct 2017Ministry of Health, Labour and Welfare
Open source archiveCheck original source
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesAdministrative Guidance
Confirmed entity match

The names of the targeted pharmaceutical products, their intended efficacy or effects, and the name or designation of the applicant are listed.

27 Oct 2015Ministry of Health, Labour and Welfare
Open source archiveCheck original source
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesAdministrative Guidance
RepeatConfirmed entity match

血栓症に関する注意喚起がなされているにもかかわらず、血栓症による国内死亡例が報告されたことを受け、医療関係者向けの情報提供資材を配布し、患者に血栓症の症状を説明し、服用中に症状が出た場合は直ちに服用を中止し救急医療機関を受診するよう指導している。

17 Jan 2014Ministry of Health, Labour and Welfare
Open source archiveCheck original source

Language

日本語版を見る (Japanese)

Registry data

English name
塩野義製薬株式会社
Japanese name
塩野義製薬株式会社
Corporate Number
9120001077430
Registered address
大阪府大阪市中央区道修町３丁目１番８号
Status
Active

Note: This company may not have detailed gBizINFO data, or RegBase has not completed enrichment yet. The public sources below may contain supplemental registry information.

View on gBizINFO ↗View on National Tax Agency Corporate Number site ↗

gBizINFO: fetched 25 Apr 2026

Data sources

Breakdown by law

Breakdown by action type

About this English name

No official English name source is recorded. The original Japanese name is shown.

If this profile contains an error or your company needs to add context, please use the correction request form. Submissions are reviewed under RegBase editorial policy.

This page mechanically aggregates and structures public government disclosures and public registry data under the editorial policy. It is not legal advice, credit scoring, or a final procurement decision. Always verify against the official source pages.